← Back to iHuman Inc.
Stoqly stoqly.net Company report Β· October 27, 2026

iHuman Inc.

IH NYSEΒ· Services-Educational Services

Last close Β· Oct 26, 2026

$1.18

KIRA Β· Stoqly’s AI analyst, in plain words

  • iHuman Inc. had $112M of revenue in fiscal 2025, down 12.4% on the year before. Over five years, revenue changed +7.8% a year on average.
  • Its operating margin was 8.3%, up 0.5Β pts: of every 100 in sales, about 8 is left after running the business.
  • iHuman Inc. made $13.3M of net profit in fiscal 2025.
  • Free cash flow was $6.5M in fiscal 2025, 5.8% of revenue.
  • iHuman Inc. returned $7.8M to shareholders in fiscal 2025, 121% of free cash flow. The diluted share count fell 1.3%.

Market cap

$63.2M

P/E

4.7x

Revenue

$112M

Net income

$13.3M

Free cash flow

$6.5M

Operating margin

8.3%

iHuman Inc. in 30 seconds Β· fiscal 2025

Weak

Are sales growing?

βˆ’12.4%

No. Sales fell 12.4% last year.

Good

Does it make a profit?

11.8%

Yes. It keeps 11.8% of every sale as profit.

So-so

Does profit turn into cash?

5.8%

Partly. 5.8% of sales ends up as free cash.

So-so

How healthy are the accounts?

4 / 8

Mixed. It passes 4 of 8 health tests.

For information

How is the share priced?

4.7x

One share costs 4.7 times its yearly profit per share.

What iHuman Inc. does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
20-F Β· Apr 24, 2026
Legal name
iHuman Inc.
CIK
0001814423
stoqly.net Β· IH Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

iHuman Inc. Β· IH

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $146M $146M $144M $128M $112M
Revenue growth 90.1% βˆ’0.1% βˆ’1.8% βˆ’10.9% βˆ’12.4%
Gross margin 69.9% 70.1% 70.8% 69.4% 67.9%
Operating margin βˆ’5.7% 11.3% 15.7% 7.8% 8.3%
Net income βˆ’$5.7M $16.3M $25.5M $13.7M $13.3M
Net margin βˆ’3.9% 11.1% 17.8% 10.7% 11.8%
Diluted EPS βˆ’$0.11 $0.30 $0.47 $0.25 $0.25
Cash
Cash from operations $5.9M $28.0M $24.3M $8.1M $7.1M
Capital expenditure $5.0M $1.0M $0.9M $1.0M $0.7M
Free cash flow $0.9M $27.0M $23.4M $7.1M $6.5M
FCF margin 0.6% 18.5% 16.3% 5.5% 5.8%
Dividends paid β€” β€” β€” $4.9M $5.4M
Share buybacks $0.0M $1.0M $1.3M $1.3M $2.4M
Share count change 17.8% 1.3% 1.3% βˆ’0.9% βˆ’1.3%
Debt and strength
Cash and short-term investments $135M $152M $171M $160M $164M
Shareholders' equity $95.8M $112M $135M $132M $142M
Current ratio 2.1x 2.2x 2.8x 3.0x 3.6x
Returns and quality
Return on equity βˆ’5.9% 15.7% 20.7% 10.3% 9.7%
Return on tangible equity βˆ’6.3% 15.1% 19.4% 10.6% 9.5%
Piotroski F-score 5 6 5 4 4
Altman Z'' 2.9 4.6 6.5 6.6 7.7

Insiders bought, 12 months

$0.0M

0 insiders

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· IH Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

iHuman Inc. Β· IH

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $1.18 a share, the company is worth $63.2M: 4.7 times its earnings of the last four quarters.

Source: SEC EDGAR XBRL filings (CIK 0001814423). Data updated October 24, 2026. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only β€” not investment advice. Check the original filings before relying on any figure.